Hostname: page-component-848d4c4894-ttngx Total loading time: 0 Render date: 2024-05-23T11:01:19.028Z Has data issue: false hasContentIssue false

Effects of intravenous yohimbine (0.3 mg/kg) on blood pressure and subjective ratings in healthy volunteers

Published online by Cambridge University Press:  28 April 2020

P. Danjou
Affiliation:
Service de Pharmacologie Clinique, Division Ambroise Paré, Hôpital de la Salpêtrière, 47, bd de l’Hôpital, 75651Paris Cedex 13, France
L. Lacomblez
Affiliation:
Service de Pharmacologie Clinique, Division Ambroise Paré, Hôpital de la Salpêtrière, 47, bd de l’Hôpital, 75651Paris Cedex 13, France
D. Warot
Affiliation:
Service de Pharmacologie Clinique, Division Ambroise Paré, Hôpital de la Salpêtrière, 47, bd de l’Hôpital, 75651Paris Cedex 13, France
A.J. Puech
Affiliation:
Service de Pharmacologie Clinique, Division Ambroise Paré, Hôpital de la Salpêtrière, 47, bd de l’Hôpital, 75651Paris Cedex 13, France
Get access

Summary

In a double-blind cross-over study realized in 8 healthy volunteers, a bolus injection of yohimbine (0.15 mg/kg) followed by an infusion (0.0025 mg/kg/min) induced a raise of blood pressure without affecting selfratings. Total dose was 0.3 mg/kg. One subject out of 8 experienced a severe anxiety episode under yohimbine and dropped out.

Résumé

Résumé

Dans un essai croisé en double aveugle réalisé sur 8 volontaires sains, l‘injection d’un bolus de 0,15 mg/kg de yohimbine suivi d’une perfusion (0,0025 mg/kg/min) a entraîné une élévation tensionnelle sans modifier l’autoévaluation. La dose totale injectée était de 0,3 mg/kg. Un sujet sur 8 a présenté un épisode aigu d ‘anxiété sous yohimbine et est sorti d’essai.

Type
Short communication
Copyright
Copyright © European Psychiatric Association 1988

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

Cattell, R.B. (1987) Handbook for the IPAT Anxiety Scale. Champain Institute for Personality and Ability Testing. French adaptation: Centre de Psychologie Appliquée, Paris, 1961Google Scholar
Charney, D.S.Heninger, G.R. & Redmond, D.E. (1983) Yohimbine induces anxiety and increases noradrenergic function in humans: effect of diazepam and clonidine. Life Sci. 33, 1929CrossRefGoogle Scholar
Charney, D.S.Heninger, G.R. & Breier, A. (1984) Noradrenergic function in panic anxiety. Arch. Gen. Psychiatry. 41, 751763CrossRefGoogle ScholarPubMed
Charney, D.S. & Heninger, G.R. (1986) Abnormal regulation of noradrenergic function in panic disorders. Arch. Gen. Psychiatry. 43, 10421054CrossRefGoogle ScholarPubMed
Eysenck, H.J. & Eysenck, S.B.G. (1968) Manual for the Eysenck Personality Inventory. Educational and Industrial Testing Service, San Diego, California. French adaptation: Centre de Psychologie Appliquée, Paris, 1971Google Scholar
Goldberg, M.R.Hollister, A.S. & Robertson, D. (1973) Influence of yohimbine on blood pressure, autonomic reflexes and plasma catecholamines in Humans. Hypertension 5, 772778CrossRefGoogle Scholar
Gorman, J.M.Askanazi, J.Liebowitz, M.R.Fyer, A.J.Stein, J.Kinney, J.M. & Klein, D.F. (1984) Response to hyperventilation in a group of patients with panic disorder. Amer. J. Psychiatry 141, 857861Google Scholar
Holmberg, G. & Gershon, S. (1961) Autonomic and psychic effects of yohimbine hydrochloride. Psychopharmacologia 2, 93106CrossRefGoogle ScholarPubMed
Holmberg, G.Gershon, S. & Beck, L. (1962) Yohimbine as an autonomic test drug. Nature 183, 13131314CrossRefGoogle Scholar
Lader, M. & Bruce, M. (1986) States of anxiety and their induction by drugs. Br. J. Clin. Pharmacol. 22, 251261CrossRefGoogle ScholarPubMed
Morales, A.Condra, M.Owen, J.A.Surridge, D.H.Fenemore, J. & Harris, C. (1987) Is yohimbine effective in the treatment of organic impotence?. Results of a controlled trial. J. Urol. 137, 11681172Google ScholarPubMed
Margraf, J.Ehlers, A. & Roth, W.T. (1986) Biological models of panic disorder and agoraphobia. A review. Behav. Res. Ther. 24, 553567CrossRefGoogle ScholarPubMed
Nutt, D.J. (1986) Increased central alpha 2-adrenoceptor sensitivity in panic disorder. Psychopharmacology 90, 268269CrossRefGoogle ScholarPubMed
Onrot, J.Goldberg, M.R.Biaggioni, I.Wiley, R.G.Hollister, A.S. & Robertson, D. (1987) Oral yohimbine in human autonomic failure. Neurology 37, 215220CrossRefGoogle ScholarPubMed
Reid, K.Morales, A.Harris, C.Surridge, D.H.C.Condra, M. & Owen, J. (1987) Double-blind trial of yohimbine in treatment of psychogenic impotence. Lancet. ii, 421423CrossRefGoogle Scholar
Schachter, S. & Wheeler, L. (1962) Epinephrine chlorpromazine and amusement. J. Abnorm. Soc. Psychol. 65, 121128CrossRefGoogle ScholarPubMed
Schachter, S. & Singer, J.E. (1962) Cognitive, social and physiological determinants of emotional State. Psychol. Rev. 69, 379399CrossRefGoogle ScholarPubMed
Smith, S.E.Pihl, R.O.Young, S.N. & Ervin, F.R. (1987) A test of possible cognitive and environmental influences on mood lowering effect of tryptophan depletion in normal males. Psychopharmacology 91, 451457CrossRefGoogle ScholarPubMed
Uhde, T.W.Roy-Byrne, P.P.Vittone, B.J.Boulenger, J.P. & Post, R.M. (1985) Phenomenology and neurobiology of panic disorder. In: Anxiety and Anxiety Disorders(Tuma, A.H. & Maser, J.D., eds.), Hillsdale & Eribaum, pp. 555576Google Scholar
Van, den Hout M.A. & Griez, E. (1982) Cognitive factors in carbon dioxide therapy. J. Psychosom. Res. 26, 209214Google Scholar
Submit a response

Comments

No Comments have been published for this article.